Skip to main content
A

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Filings indexed 389 across all filing types
Latest filing 2023-08-07 Regulatory Filings
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Atomo Completes Successful Capital Raising 3 pages 212.9KB
Regulatory Filings
2023-08-07 English
Application for quotation of securities - AT1 6 pages 28.1KB
Regulatory Filings
2023-08-07 English
Notification of cessation of securities - AT1 4 pages 23.9KB
Regulatory Filings
2023-08-02 English
Update - Proposed issue of securities - AT1 7 pages 32.7KB
Regulatory Filings
2023-07-27 English
Appendix 4C - 30 June 2023 5 pages 849.1KB
Regulatory Filings
2023-07-26 English
Quarterly Activity Report - 30 June 2023 6 pages 188.4KB
Regulatory Filings
2023-07-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.